Vagus nerve stimulation enhances remyelination and decreases innate neuroinflammation in lysolecithin-induced demyelination
Brain Stimulation · 2024-05 · 17 (3) · 575-587
DOI: 10.1016/j.brs.2024.04.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Stimulation, 2024-05. Verfasst von Helen Bachmann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ghent University, 4 Brain, Department of Neurology, Ghent University Hospital, Belgium. Electronic address: Helen.Bachmann@UGent.be. Hauptthemen laut MEDLINE: Remyelination, Lysophosphatidylcholines, Demyelinating Diseases, Rats, Inbred Lew. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Charcot Stichting, Research Foundation Flanders.
Abstract (Originalsprache)
BACKGROUND: Current treatments for Multiple Sclerosis (MS) poorly address chronic innate neuroinflammation nor do they offer effective remyelination. The vagus nerve has a strong regulatory role in inflammation and Vagus Nerve Stimulation (VNS) has potential to affect both neuroinflammation and remyelination in MS. OBJECTIVE: This study investigated the effects of VNS on demyelination and innate neuroinflammation in a validated MS rodent model. METHODS: Lysolecithin (LPC) was injected in the corpus callosum (CC) of 46 Lewis rats, inducing a demyelinated lesion. 33/46 rats received continuously-cycled VNS (cVNS) or one-minute per day VNS (1minVNS) or sham VNS from 2 days before LPC-injection until perfusion at 3 days post-injection (dpi) (corresponding with a demyelinated lesion with peak inflammation). 13/46 rats received cVNS or sham from 2 days before LPC-injection until perfusion at 11 dpi (corresponding with a partial remyelinated lesion). Immunohistochemistry and proteomics analyses were performed to investigate the extend of demyelination and inflammation. RESULTS: Immunohistochemistry showed that cVNS significantly reduced microglial and astrocytic activation in the lesion and lesion border, and significantly reduced the Olig2+ cell count at 3 dpi. Furthermore, cVNS significantly improved remyelination with 57.4 % versus sham at 11 dpi. Proteomic gene set enrichment analyses showed increased activation of (glutamatergic) synapse pathways in cVNS versus sham, most pronounced at 3 dpi. CONCLUSION: cVNS improved remyelination of an LPC-induced lesion. Possible mechanisms might include modulation of microglia and astrocyte activity, increased (glutamatergic) synapses and enhanced oligodendrocyte clearance after initial injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ghent University, 4 Brain, Department of Neurology, Ghent University Hospital, Belgium. Electronic address: Helen.Bachmann@UGent.be.
- Laboratory for Computational Biology, Integromics and Gene Regulation (CBIGR), Cancer Research Institute Ghent (CRIG), Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium; Depart…
- Ghent University, 4 Brain, Department of Neurology, Ghent University Hospital, Belgium.
Förderung
- Charcot Stichting
- Research Foundation Flanders
Zitieren
APA
Bachmann, H., Vandemoortele, B., Vermeirssen, V., Carrette, E., Vonck, K., Boon, P., Raedt, R., & Laureys, G. (2024). Vagus nerve stimulation enhances remyelination and decreases innate neuroinflammation in lysolecithin-induced demyelination. Brain Stimulation, 17(3), 575-587. https://doi.org/10.1016/j.brs.2024.04.012
Vancouver
Bachmann H, Vandemoortele B, Vermeirssen V, Carrette E, Vonck K, Boon P, et al. Vagus nerve stimulation enhances remyelination and decreases innate neuroinflammation in lysolecithin-induced demyelination. Brain Stimulation. 2024;17(3):575-587. doi:10.1016/j.brs.2024.04.012
BibTeX
@article{Bachmann2024,
author = {Bachmann, Helen and Vandemoortele, Boris and Vermeirssen, Vanessa and Carrette, Evelien and Vonck, Kristl and Boon, Paul and Raedt, Robrecht and Laureys, Guy},
title = {Vagus nerve stimulation enhances remyelination and decreases innate neuroinflammation in lysolecithin-induced demyelination},
journal = {Brain Stimulation},
year = {2024},
volume = {17},
number = {3},
pages = {575--587},
doi = {10.1016/j.brs.2024.04.012}
}
EUVIMED